Elevance Health, Inc.
ELV
$387.08
$4.851.27%
NYSE
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 0.46% | 1.47% | |||
| Total Other Revenue | 1.18% | -2.02% | |||
| Total Revenue | 0.58% | 0.87% | |||
| Cost of Revenue | 3.96% | -6.44% | |||
| Gross Profit | -7.66% | 24.68% | |||
| SG&A Expenses | -6.39% | 9.67% | |||
| Depreciation & Amortization | -1.79% | -31.71% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.37% | -2.98% | |||
| Operating Income | -13.53% | 247.39% | |||
| Income Before Tax | -15.93% | 971.63% | |||
| Income Tax Expenses | -11.21% | 264.35% | |||
| Earnings from Continuing Operations | -17.39% | 222.34% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 125.00% | 300.00% | |||
| Net Income | -17.06% | 222.49% | |||
| EBIT | -13.53% | 247.39% | |||
| EBITDA | -11.54% | 157.25% | |||
| EPS Basic | -15.99% | 225.42% | |||
| Normalized Basic EPS | -14.45% | 482.00% | |||
| EPS Diluted | -16.13% | 224.39% | |||
| Normalized Diluted EPS | -14.57% | 480.41% | |||
| Average Basic Shares Outstanding | -1.27% | -0.90% | |||
| Average Diluted Shares Outstanding | -1.13% | -0.63% | |||
| Dividend Per Share | 0.00% | 0.58% | |||
| Payout Ratio | 0.20% | -0.69% | |||